CLU has been linked to AD as a genetic risk factor62,63, and in the APP/presenilin 1 (PS1) mouse model, loss of CLU resulted in a marked reduction in parenchymal amyloid deposition but a dramatic increase in CAA64. This evidence concerns the gene APP and Alzheimer disease.